Martina Nacach Rowan Cos Mariana Matus (left) and Newsha Ghaeli, co-founders of Biobot Analytics, in November 2025.

Cambridge wastewater detection company Biobot Analytics received a new round of venture capital , which will help it expand beyond its traditional public health market and into the private sector, helping identify trends in infectious disease outbreaks and clusters of drug use.

The new round of funding, announced in June, was for an undisclosed amount. It was led by private investment firm Valor Equity Partners. Biobot also added three people to its board of directors, including Vivjan Myrto, managing partner and venture capital firm Hyperplane. Myrto said he has watched Biobot grow since Hyperplane first invested in it in 2017, the year the company was founded by Marian

See Full Page